Bpx-501 T Cells: Clinical Trials

1 trial of Bpx-501 T Cells, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1
Phase 31Terminated 1

Follow Bpx-501 T Cells: new trials by email Literature Review of Bpx-501 T Cells trials Research Report on Bpx-501 T Cells

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Haplo-HSCT + Rivogenlecleucel vs Haplo-HSCT + Post Transplant Cyclophosphamide in Patients With AML or MDS
rivogenlecleucel, rimiducid, Cyclophosphamide - Acute Myeloid Leukemia, Myelodysplastic Syndromes
Phase 2 / Phase 3TerminatedBellicum Pharmaceuticals12018-12-272023-09-29

Conditions studied

Leukemia, Myeloid, Acute (1)  ·  Myelodysplastic Syndromes (1)

Sponsors

Bellicum Pharmaceuticals (1)

Countries

United States (1)